[HMS: Medical Human Story–Episode 72]-Part II: One Word in a Pathology Report—MALT Lymphoma
Part II: One Word in a Pathology Report—MALT Lymphoma
The Longest Time Is Waiting
Pathology results usually take only a few days.
But for patients, those days outside the hospital are never short.
A single day stretches like a week. Nights fall heavily, as though they
will never end.
Park Jun-ho and his wife, Kim Jeong-sook, were living through that cruel
suspension of time.
She cooked stew and rice as she always had, but the table was filled with
silence.
He unfolded the newspaper, though the words never seemed to enter his
mind—only blank ink floating on white paper.
They avoided each other’s gaze, each pretending that life was still
ordinary.
That nothing had changed.
"What if… it’s cancer?" his wife finally asked, her voice trembling as she set down a glass of
water.
He paused with his chopsticks.
Silence.
"Let’s think about that when the results come," he said at last.
"Aren’t you afraid?"
He slowly turned his gaze toward the sunset outside the living room
window.
"Of course I’m afraid," he said quietly. "Why wouldn’t I be?"
His voice lingered in the air.
"But more than myself… I’m more worried about how you’ll endure
it."
His wife bit her lip and said nothing.
Disease harms one body.
But the fear of disease spreads through an entire family like an invisible infection.
The Silent Microscope of Pathology
In the pathology laboratory, tiny fragments of tissue were placed
carefully onto glass slides.
H&E staining revealed cellular architecture.
Then, immunohistochemical staining (IHC) was performed to define the nature
of the malignancy.
Under the microscope, the pathologist identified lymphoepithelial
lesions—clusters of small B-cells aggressively infiltrating the mucosa.
The diagnostic signature became increasingly clear as markers such as
CD20, CD79a, and BCL-2 were evaluated.
This was not a typical lymphoma.
It carried the distinctive molecular fingerprint of MALT lymphoma.
[Medical Insight] Immunophenotype of Colonic MALT Lymphoma
[Figure Insert]
A Single Line That Changes a Life
Two days later, the report arrived on my screen.
Diagnosis: Extranodal marginal zone B-cell lymphoma of mucosa-associated
lymphoid tissue (MALT lymphoma).
I stared at the words for a long time.
I had already suspected the diagnosis.
And yet, seeing it written in cold, definitive language always carries a
different weight.
A single sentence like this does not simply describe disease.
It redefines the remainder of a person’s life.
Everything they had planned, imagined, postponed—compressed into a line of
pathology text.
A physician treats the body.
But it is also forced to carry the emotional gravity of its consequences.
The Moment of Truth
At 3 p.m., the consultation room door opened.
Park Jun-ho and his wife stepped inside.
They both looked as though they had not slept.
I gestured for them to sit, then allowed a moment of silence.
Delivering results is never routine. Even after years in medicine, it
remains a kind of ritual that never becomes easier.
"The test results are back," I said.
His wife inhaled sharply.
"The findings indicate a lymphoma."
Silence filled the room.
In those few seconds, I saw their expressions collapse—not dramatically,
but quietly, like structures yielding under invisible weight.
"Is it cancer?" she asked.
"Yes," I replied.
Tears welled in her eyes.
The husband lowered his head, silent.
Then I continued.
"It is a colonic MALT lymphoma. Fortunately, it is a low-grade
lymphoma that grows slowly. It is treatable, and the prognosis is generally
favorable."
Only then did they exhale—breath they had not realized they were holding.
The Weight of the Word “Cancer”
To physicians, cancer is part of daily vocabulary.
To patients, it is the moment life stops.
It takes hostage all imagined futures:
Tomorrow’s travel plans.
A promise to a grandchild.
Quiet dreams of retirement.
One word rewrites everything.
"Can I really survive this?" the wife asked, her voice trembling.
I closed the chart and met his eyes directly.
"Yes. Absolutely. But we will need to fight it together."
At that moment, she broke into tears.
But it was not despair.
It was something more complex—relief intertwined with fear.
A deeply human release.
Rare Cancer, Lost in the Sea of Information
"It’s so rare… I’m scared," the husband said.
His fear was understandable.
This disease accounts for less than 1% of colorectal malignancies. Many
clinicians encounter it only once—or never—in their entire careers.
Yet I needed to reassure him.
"Rarity does not mean worse outcomes," I said.
"In fact, colonic MALT lymphoma often has a better prognosis than
conventional colorectal cancer when detected early."
He nodded slowly.
From this point forward, the process would shift toward staging the disease precisely and defining the therapeutic path.
[Medical Insight]Staging of Colonic MALT Lymphoma
[Figure Insert]
The Journey Home: The Beginning of the Fight
Their steps leaving the hospital were heavy.
Even inside the elevator, silence persisted.
Even on the way to the parking lot, no one spoke.
Finally, in the car, the wife broke the silence.
"What do we do now?"
He stared out the window for a long time.
Then, in a low but steady voice, he said:
"We live. We live together."
She cried again.
Doctors make diagnoses in hospitals.
But the real battle begins when the patient returns home and closes the
door.
From that moment, uncertainty begins its daily assault—through search engines, rumors, fear, and sleepless nights.
Multidisciplinary Conference and the Beginning of
Treatment
Further tests, fortunately, revealed no distant metastasis.
The disease was localized and at an early stage.
A multidisciplinary meeting was held involving gastroenterology,
hematology-oncology, radiology, and pathology.
"Instead of surgery, Rituximab-based immunotherapy would preserve
quality of life while effectively targeting malignant B-cells," the consensus concluded.
The treatment plan was established.
It became the engine that would restart Park Jun-ho’s daily life.
[Medical Insight] Treatment Options for Colonic MALT
Lymphoma
[Figure Insert]
A Granddaughter’s Entrance Ceremony: What Medicine
Must Protect
After the consultation ended, Park Jun-ho paused at the door and turned
back.
"Professor," he said quietly, "my
granddaughter will enter elementary school next spring. Will I… be able to be
there?"
I found myself momentarily speechless.
Not statistics.
Not survival curves.
But a simple image: a grandfather holding his granddaughter’s hand as she
walks through the school gates.
I smiled.
"We will do everything we can to make sure you are there."
He nodded, visibly relieved.
Medicine is not merely the prolongation of life.
It is the preservation of ordinary days shared with those we love.
That is its true purpose.
[Medical Recommendations] – Part II
The above content is a web novel adapted from the article published on https://leesangbock.blogspot.com/2026/06/colonic-malt-lymphoma-ct-imaging-ai-healthcare.html. |
Part I: When Did the Abdominal Pain Begin?☜ Previous Chapter
Next Chapter ☞Part III: On the Day Chemotherapy Began, the Elderly Couple Cried in Front of Each Other for the First Time
Comments
Post a Comment